- In the United States, some major drug plan insurers have implemented tablet-splitting programs that target statins.
- Tablet splitting has been shown to reduce prescription costs substantially without negatively affecting laboratory outcomes or compliance
- In addition, patients have found tablet splitting to be simple and acceptable
Supporting Evidence
- A retrospective chart review of total cholesterol and LDL cholesterol values of patients instructed to split simvastatin or atorvastatin between January 1999 and November 2000
- The overall results for this review demonstrated no statistically significant increase in total cholesterol and LDL cholesterol concentrations. Total cholesterol and LDL cholesterol values actually decreased from presplitting to postsplitting, p = 0.017 and p = 0.003, respectively.
Manufacturers Recommendations
- No information provided on tablet splitting
- Most drug companies oppose pill-splitting. They say it can be dangerous. But studies to date have not shown any adverse impact on health on the drugs listed safe to be split
Not To be Split
- combination medications such as Liptruzet (atorvastatin/ezetimibe), Advicor (lovastatin/niacin) or Vytorin (simvastatin/ezetimibe)
- time-release drugs, such as Altoprev (lovastatin sustained-release tablets), or Lescol XL (fluvastatin sustained-release tablets)
Ways to Split
- don’t use a knife—studies show doing so can result in unequal halves. Instead, get a pill splitter device.
- A good practice is to split your pills one at a time, and take the second half as your next dose
References:
- https://www.consumerreports.org/cro/news/2014/03/is-it-safe-to-split-my-statin-cholesterol-drug-to-save-money/index.htm
- https://www.ncbi.nlm.nih.gov/pubmed/11847935
- Dormuth CR, Schneeweiss S, Brookhart AM, Carney G, Bassett K, Adams S, Wright JM. Open Med 2008;2(3):5–13
- January 1, 2006 University of Michigan Prescription Drug Plan
Post a Comment